Skip to main content
Sister Publication Links
  • ESG: THE NEW IMPERATIVE
Subscribe
  • My Account
  • Login
  • Subscribe
  • News
    • Current News
    • COVID-19
    • Providers
    • Insurance
    • Government
    • Finance
    • Technology
    • Safety & Quality
    • Transformation
    • People
    • Regional News
    • Digital Edition (Web Version)
    • Patients
    • Operations
    • Care Delivery
    • Payment
    • Midwest
    • Northeast
    • South
    • West
  • Digital Health
  • Insights
    • ACA 10 Years After
    • Best Practices
    • Special Reports
    • Innovations
  • Data/Lists
    • Rankings/Lists
    • Interactive Databases
    • Data Points
  • Opinion
    • Bold Moves
    • Breaking Bias
    • Commentaries
    • Letters
    • Vital Signs Blog
    • From the Editor
  • Events & Awards
    • Awards
    • Conferences
    • Galas
    • Virtual Briefings
    • Custom Media Event: ESG Summit
    • Webinars
    • Nominate/Eligibility
    • 100 Most Influential People
    • 50 Most Influential Clinical Executives
    • Best Places to Work in Healthcare
    • Excellence in Governance
    • Health Care Hall of Fame
    • Healthcare Marketing Impact Awards
    • Top 25 Emerging Leaders
    • Top 25 Innovators
    • Diversity in Healthcare
      • - Luminaries
      • - Top 25 Diversity Leaders
      • - Leaders to Watch
    • Women in Healthcare
      • - Luminaries
      • - Top 25 Women Leaders
      • - Women to Watch
    • Leadership Symposium
    • Social Determinants of Health Symposium
    • Transformation Summit
    • Women Leaders in Healthcare Conference
    • Best Places to Work Awards Gala
    • Health Care Hall of Fame Gala
    • Top 25 Diversity Leaders Gala
    • Top 25 Women Leaders Gala
    • - Hospital of the Future
    • - Value Based Care
    • - Supply Chain Revenue Cycle
    • - Hospital at Home
    • - Workplace of the Future
    • - Virtual Health
    • - Future of Healthcare Staffing
  • Multimedia
    • Podcast - Beyond the Byline
    • Sponsored Podcast - Healthcare Insider
    • Video Series - The Check Up
    • Sponsored Video Series - One on One
  • MORE +
    • Advertise
    • Media Kit
    • Newsletters
    • Jobs
    • People on the Move
    • Reprints & Licensing
MENU
Breadcrumb
  1. Home
  2. Finance
January 06, 2017 12:00 AM

Drug spending for some Medicare enrollees has tripled since 2010

Virgil Dickson
  • Tweet
  • Share
  • Share
  • Email
  • More
    Reprints Print

    Drug spending for some Medicare beneficiaries has increased at an alarming rate, a new federal report finds.

    Federal payments for Medicare Part D catastrophic coverage exceeded $33 billion in 2015, which is more than triple the amount paid in 2010, according to an HHS Office of Inspector General report released Thursday.

    The catastrophic drug benefit under Medicare Part D is meant to cover costs for beneficiaries with chronic conditions who quickly rack up high drug expenses. The coverage kicks in after beneficiaries spend $4,850 out of pocket.

    After that, taxpayers pay for 80% of the cost of medications. The beneficiary pays 5%, and insurers pay the remaining 15%.

    About 8.7% of Medicare beneficiaries trigger the catastrophic drug coverage clause. Of the 41 million enrollees in Part D in 2015, only 3.6 million needed it. However, that figure is a 53% jump from the enrollees with catastrophic coverage in 2010.

    By 2015, high-price drugs were responsible for almost two-thirds of the total drug spending in catastrophic coverage. That's a huge increase from 2010, when high-price drugs were responsible for one-third of the spending, the OIG report found.

    The two most expensive drugs were Harvoni, which treats hepatitis C and costs catastrophic enrollees an average of $33,000 a month, and Revlimid, a blood cancer medication which costs more than $11,000 a month.

    The federal watchdog suggested that the CMS needs to more closely regulate Part D. One idea is restructuring the program so that Part D plans have more incentives and opportunities to lower costs. Another is revising the law to allow HHS to negotiate prices for certain drugs.

    It's unclear how Capitol Hill will respond to the report. A GOP Hill staffer said some legislative action on drug pricing could take place when Congress reauthorizes the Prescription Drug User Fee Act, or PDUFA, which allows the Food and Drug Administration to collect fees from drug companies to give them the resources, such as staffing to expedite approval of new therapies. Fees can range from $500,000 to $1 million.

    The PDUFA must be reauthorized every five years, and is set to end in September 2017. Since it's a must-pass bill, some see it as a possible vehicle for legislation to curb rising prescription drug prices, he said.

    However, the struggle lawmakers face is how to ensure access to drugs and solvency of the Medicare trust fund, while at the same time not discouraging the creation of innovative products.

    President-elect Donald Trump's HHS secretary pick, Rep. Tom Price (R-Ga.), has sent out mixed signals on his interest in reining in drug spending for the Medicare program.

    He led opposition to a recently canceled payment model that aimed to cut drug spending under Medicare Part B. He said the CMS didn't receive enough stakeholder feedback, and that the agency focused too much on lowering spending without ensuring access to drugs when developing the initiative. On the other hand, he has also said he'll prioritize ways to reduce spending in the Medicare program.

    Letter
    to the
    Editor

    Send us a letter

    Have an opinion about this story? Click here to submit a Letter to the Editor, and we may publish it in print.

    Recommended for You
    Jason Hollar
    Cardinal Health names new CEO, plans price increases to bolster earnings
    Kaiser Permanente
    Kaiser Permanente has a rough first half as Q2 net loss exceeds $1B
    Sponsored Content
    Daily Finance Newsletter: Sign up to receive daily news and data that has a direct impact on the business and financing of healthcare.
    Get Newsletters

    Sign up for enewsletters and alerts to receive breaking news and in-depth coverage of healthcare events and trends, as they happen, right to your inbox.

    Subscribe Today
    MH Magazine Cover

    MH magazine offers content that sheds light on healthcare leaders’ complex choices and touch points—from strategy, governance, leadership development and finance to operations, clinical care, and marketing.

    Subscribe
    Connect with Us
    • LinkedIn
    • Twitter
    • Facebook
    • RSS

    Our Mission

    Modern Healthcare empowers industry leaders to succeed by providing unbiased reporting of the news, insights, analysis and data.

    Contact Us

    (877) 812-1581

    Email us

     

    Resources
    • Contact Us
    • Advertise with Us
    • Ad Choices Ad Choices
    • Sitemap
    Editorial Dept
    • Submission Guidelines
    • Code of Ethics
    • Awards
    • About Us
    Legal
    • Terms and Conditions
    • Privacy Policy
    • Privacy Request
    Modern Healthcare
    Copyright © 1996-2022. Crain Communications, Inc. All Rights Reserved.
    • News
      • Current News
      • COVID-19
      • Providers
      • Insurance
      • Government
      • Finance
      • Technology
      • Safety & Quality
      • Transformation
        • Patients
        • Operations
        • Care Delivery
        • Payment
      • People
      • Regional News
        • Midwest
        • Northeast
        • South
        • West
      • Digital Edition (Web Version)
    • Digital Health
    • Insights
      • ACA 10 Years After
      • Best Practices
      • Special Reports
      • Innovations
    • Data/Lists
      • Rankings/Lists
      • Interactive Databases
      • Data Points
    • Opinion
      • Bold Moves
      • Breaking Bias
      • Commentaries
      • Letters
      • Vital Signs Blog
      • From the Editor
    • Events & Awards
      • Awards
        • Nominate/Eligibility
        • 100 Most Influential People
        • 50 Most Influential Clinical Executives
        • Best Places to Work in Healthcare
        • Excellence in Governance
        • Health Care Hall of Fame
        • Healthcare Marketing Impact Awards
        • Top 25 Emerging Leaders
        • Top 25 Innovators
        • Diversity in Healthcare
          • - Luminaries
          • - Top 25 Diversity Leaders
          • - Leaders to Watch
        • Women in Healthcare
          • - Luminaries
          • - Top 25 Women Leaders
          • - Women to Watch
      • Conferences
        • Leadership Symposium
        • Social Determinants of Health Symposium
        • Transformation Summit
        • Women Leaders in Healthcare Conference
      • Galas
        • Best Places to Work Awards Gala
        • Health Care Hall of Fame Gala
        • Top 25 Diversity Leaders Gala
        • Top 25 Women Leaders Gala
      • Virtual Briefings
        • - Hospital of the Future
        • - Value Based Care
        • - Supply Chain Revenue Cycle
        • - Hospital at Home
        • - Workplace of the Future
        • - Virtual Health
        • - Future of Healthcare Staffing
      • Custom Media Event: ESG Summit
      • Webinars
    • Multimedia
      • Podcast - Beyond the Byline
      • Sponsored Podcast - Healthcare Insider
      • Video Series - The Check Up
      • Sponsored Video Series - One on One
    • MORE +
      • Advertise
      • Media Kit
      • Newsletters
      • Jobs
      • People on the Move
      • Reprints & Licensing